Frank Leonard

Frank Leonard

Chief Executive OfficeratNovoCure· In proxies 2023–2025

Pay in FY2025+20% from the year before · NovoCure stock -56.6% the same year

Frank Leonard was paid $7.0M in FY2025 (Dec), up 20%. NovoCure stock fell 56.6% that year.

Pay$100 in the stock at the end of FY22 → $18
Pay is from the Summary Compensation Table of each NovoCure proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NovoCurePublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?